Literature DB >> 16134563

The relationship between blood lead levels and neurobehavioral test performance in NHANES III and related occupational studies.

Edward F Krieg1, David W Chrislip, Carlos J Crespo, W Stephen Brightwell, Richard L Ehrenberg, David A Otto.   

Abstract

OBJECTIVES: The goals of this study were two-fold: (1) to assess the relationship between blood lead levels and neurobehavioral test performance in a nationally sample of adults from the third National Health and Nutrition Evaluation Survey and (2) to analyze the results from previously published studies of occupational lead exposure that used the same neurobehavioral tests as those included in the survey.
METHODS: Regression models were used to test and estimate the relationships between measurements of blood lead and performance on a simple reaction time, a symbol-digit substitution, and a serial digit learning test in adults aged 20-59 years who participated the survey. Mixed models were used to analyze the data from the occupational studies.
RESULTS: The blood lead levels of those participating in the survey ranged from 0.7 to 41.8 microg/dl. The estimated geometric mean was 2.51 microg/dl, and the estimated arithmetic mean was 3.30 microg/dl. In the survey, no statistically significant relationships were found between blood lead concentration and performance on the three neurobehavioral tests when adjusted for covariates. In the occupational studies, the groups exposed to lead consistently performed worse than control groups on the simple reaction time and digit-symbol substitution tests.
CONCLUSIONS: The results from the survey and the occupational studies do not provide evidence for impairment of neurobehavioral test performance at levels below 25 microg/dl, the concentration that the Centers for Disease Control and Prevention define as elevated in adults. The average blood lead level of the exposed groups in the occupational studies was 41.07 microg/dl, less than 50 microg/dl, the minimum concentration that the Occupational Safety and Health Administration requires for medical removal from the workplace. Given the evidence of impaired neurobehavioral performance in these groups, the 50 microg/dl limit should be reevaluated.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16134563      PMCID: PMC1497718          DOI: 10.1177/003335490512000305

Source DB:  PubMed          Journal:  Public Health Rep        ISSN: 0033-3549            Impact factor:   2.792


  32 in total

1.  A comprehensive neurobehavioral and neurophysiological study for low level lead-exposed workers.

Authors:  Q Niu; S C He; H Y Li; J Y Wang; F Y Dai; Y L Chen
Journal:  G Ital Med Lav Ergon       Date:  2000 Oct-Dec

Review 2.  Subclinical neurophysiological effects of lead: A review on peripheral, central, and autonomic nervous system effects in lead workers.

Authors:  S Araki; H Sato; K Yokoyama; K Murata
Journal:  Am J Ind Med       Date:  2000-02       Impact factor: 2.214

3.  Neurobehavioral test performance in the third National Health and Nutrition Examination Survey.

Authors:  E F Krieg; D W Chrislip; R E Letz; D A Otto; C J Crespo; W S Brightwell; R L Ehrenberg
Journal:  Neurotoxicol Teratol       Date:  2001 Nov-Dec       Impact factor: 3.763

4.  Cognitive deficits associated with blood lead concentrations <10 microg/dL in US children and adolescents.

Authors:  B P Lanphear; K Dietrich; P Auinger; C Cox
Journal:  Public Health Rep       Date:  2000 Nov-Dec       Impact factor: 2.792

5.  Reduced cognitive abilities in lead-exposed men.

Authors:  Alfred Barth; Andreas W Schaffer; Wolf Osterode; Robert Winker; Christophoros Konnaris; Eva Valic; Christian Wolf; Hugo W Rüdiger
Journal:  Int Arch Occup Environ Health       Date:  2002-04-25       Impact factor: 3.015

6.  Cumulative blood lead levels and neurobehavioral test performance.

Authors:  S E Chia; H P Chia; C N Ong; J Jeyaratnam
Journal:  Neurotoxicology       Date:  1997       Impact factor: 4.294

7.  Behavioral indicators of lead neurotoxicity: results of a clinical field survey.

Authors:  J A Valciukas; R Lilis; J Eisinger; W E Blumberg; A Fischbein; I J Selikoff
Journal:  Int Arch Occup Environ Health       Date:  1978-07-14       Impact factor: 3.015

8.  Assessment of neurobehavioral performance as a function of current and cumulative occupational lead exposure.

Authors:  R Lucchini; E Albini; I Cortesi; D Placidi; E Bergamaschi; F Traversa; L Alessio
Journal:  Neurotoxicology       Date:  2000-10       Impact factor: 4.294

9.  Validity of a computer-assisted neurobehavioral test battery in toxicant encephalopathy.

Authors:  S P Proctor; R Letz; R F White
Journal:  Neurotoxicology       Date:  2000-10       Impact factor: 4.294

10.  Associations of blood lead, dimercaptosuccinic acid-chelatable lead, and tibia lead with neurobehavioral test scores in South Korean lead workers.

Authors:  B S Schwartz; B K Lee; G S Lee; W F Stewart; S S Lee; K Y Hwang; K D Ahn; Y B Kim; K I Bolla; D Simon; P J Parsons; A C Todd
Journal:  Am J Epidemiol       Date:  2001-03-01       Impact factor: 4.897

View more
  5 in total

1.  Physiologic dysfunction scores and cognitive function test performance in U.S. adults.

Authors:  Roni W Kobrosly; Christopher L Seplaki; Courtney M Jones; Edwin van Wijngaarden
Journal:  Psychosom Med       Date:  2011-12-07       Impact factor: 4.312

2.  Developmental Lead Exposure in Rats Causes Sex-Dependent Changes in Neurobiological and Anxiety-Like Behaviors that Are Improved by Taurine Co-treatment.

Authors:  George B Cruz; Michelle A Vasquez; Ericka Cabañas; Jewel N Joseph; Jourvonn C Skeen; Kirsten P Lynch; Isra Ahmed; Eric B Khairi; Jalen R Bonitto; Evan G Clarke; Samantha Rubi; Nimra Hameed; Sukhpreet Kaur; Neena Mathew; Teddy F Dacius; Tokunbo J Jose; Gabriella Handford; Samuel Wolfe; Alex Feher; Kyle Tidwell; Jon Tobin; Enero Ugalde; Samantha Fee; Allison Choe; Katherine Gillenwater; Bilal Hindi; Shawna Pilout; Nick R Natale; Nick Domahoski; Molly H Kent; Joanna C Jacob; Kelly G Lambert; Lorenz S Neuwirth
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

3.  In Vivo Sex-Dependent Effects of Perinatal Pb2+ Exposure on Pilocarpine-Induced Seizure Susceptibility and Taurine Neuropharmacology.

Authors:  Michelle A Vasquez; George B Cruz; Ericka Cabañas; Jewel N Joseph; Mohammad Mian; Sai Karthik V Madhira; Chelsea A Akintunde; Evan G Clarke; Jourvonn C Skeen; Jalen R Bonitto; Eric B Khairi; Kirsten P Lynch; Narmin H Mekawy; Abdeslem El Idrissi; Youngjoo Kim; Bright U Emenike; Lorenz S Neuwirth
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

4.  Taurine-Derived Compounds Produce Anxiolytic Effects in Rats Following Developmental Lead Exposure.

Authors:  Lorenz S Neuwirth; Bright U Emenike; George B Cruz; Ericka Cabañas; Michelle A Vasquez; Jewel N Joseph; Zaid Ayaz; Mohammed Mian; Mohamed M Ali; Evan G Clarke; Eddy D Barrera; Nimra Hameed; Samantha Rubi; Teddy F Dacius; Jourvonn C Skeen; Jalen R Bonitto; Eric B Khairi; Asma Iqbal; Isra Ahmed; Tokunbo J Jose; Kirsten P Lynch; Amber Alivira; Neena Mathew; Sukhpreet Kaur; Sidrah Masood; Bettina Tranquilee; Veni Thiruverkadu
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

Review 5.  Recommendations for medical management of adult lead exposure.

Authors:  Michael J Kosnett; Richard P Wedeen; Stephen J Rothenberg; Karen L Hipkins; Barbara L Materna; Brian S Schwartz; Howard Hu; Alan Woolf
Journal:  Environ Health Perspect       Date:  2006-12-22       Impact factor: 9.031

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.